YOUNG DAVID (Chief Executive Officer) purchased 11.6% of their position (1.79K shares) of PROCESSA PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $4.6K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/1/2026ACC: 0000897069-26-001295
DirectorOfficer· Chief Executive Officer
Since Oct 2020
+1.79K
Net shares
Net buyer
$4.6K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
1.79K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+1.79K
Price / share
$2.57
Trade value
$4.59K
% of position
11.6%
5/29/2026
15.35K→17.13K
Total
Net shares
+1.79K
Net value
$4.59K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/29/2026 | P · Purchase | +1.79K | $2.57 | $4.59K | 11.6% | 15.35K | 17.13K |
| Total | +1.79K | $4.59K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned1.24K
Common Stock
IndirectShares owned742.00
Common Stock
IndirectShares owned432.00
Total
2.42K indirect2.42K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.24K | Indirect |
| Common Stock | 742.00 | Indirect |
| Common Stock | 432.00 | Indirect |
| Total | 2.42K | 2.42K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported